Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - RESEARCH & DEVELOPMENT
Research & Development REGN - Regeneron Pharmaceuticals, Inc.
5.13 B
LAST VALUE
19.52%
2 YEAR CAGR
11.07%
5 YEAR CAGR
14.97%
10 YEAR CAGR